U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 3-9, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 3-9, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 07/04/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Stephen Cha (Health and Human Services); Mark Sacofsky, Moses Feldman, Sussy Kraus (Global Group/Global Kosher);

Event Date: 07/05/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Monica Wilkins, Robert Ford, Thomas Evers (Abbot Laboratories); Sean McCluskie, Stephen Cha, Xavier Becerra (Health and Human Services);

Event Date: 07/05/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Sean McCluskie, Stephen Cha (Health and Human Services); Cheryl Callen, Molly Fogarty, Tarun Malkani (Gerber Products Company);

Event Date: 07/05/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Alexandre Biella, Arthur Pike, Audrae Erickson, Justin Griner, Niall Mullane, Robert Cleveland (Reckitt); Stephen Cha, Sean McCluskie, Xavier Becerra (Health and Human Services);

Event Date: 07/06/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Anne Laraway, Brian Kineman, Chris Adamo, Miguel Del Toro, Nancy Dowling, Shane Grant (Danone);

Event Date: 07/06/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jeremy Robbins, Paul Fitzpatrick, Tarsi Luo (Bellamy's Organic); Stephen Cha (Health and Human Services);

Event Date: 07/06/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Craig Hadley, Dylan McMahon, Luke Douglas, Pippa Hunter, Ross McMahon, Thomas Hammer, Will McMahon (Kendal Nutricare);

Event Date: 07/06/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Sean McCluskie, Stephen Cha (Health and Human Services); Chris Kapral, Jim Dillard, Murray Kessler (Perrigo);

Event Date: 07/06/2022
Location: Virtual
Subject: The Role of Academic Medicine in Working With the FDA
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: David Skorton, Heather Pierce, Ross McKinney, Tannaz Rasouli (Association of American Medical Colleges);

Event Date: 07/06/2022
Location: Virtual
Subject: FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Meredith Yinger, Shawn Martin, Stephanie Quinn (American Academy of Family Physicians);

Event Date: 07/08/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in the infant formula issue

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 07/06/2022
Location: Virtual
Subject: Patient-Centered Outcomes Research Institute (PCORI) Additional Cycle 3 2021 Selection Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Multiple PCORI Selection Committee members

Event Date: 07/08/2022
Location: Virtual
Subject: Briefing for House Energy and Commerce and Senate Health, Education, Labor and Pensions (HELP) User Fee Carryover and Reauthorization Timing
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Congressional staff

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/07/2022
Location: Virtual
Subject: Digital Transformation Lessons from COVID-19
FDA Participant/Group: DONALD PRATER; ADAM FRIEDLANDER;
Non FDA Participant/Group: Attendees from Food Standards Australia and New Zealand, Singapore Food Agency, Food Standards Agency London, Food Safety Authority of Ireland, and Health Canada

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/04/2022
Location: Geneva, Switzerland
Subject: Member State Mechanism on Substandard and Falsified Medical Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Paul Huleatt (World Health Organization (WHO));

Event Date: 07/08/2022
Location: Brussels, Belgium
Subject: Building the FDA Relationship With the New EU Health Emergency Preparedness and Response Authority Entity
FDA Participant/Group: N/A
Non FDA Participant/Group: Pierre Delsaux (European Commission);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/06/2022
Location: Virtual
Subject: Circulating Tumor DNA (CTDNA) for Early-Stage Solid Tumor Drug Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Ellen Sigal (Friends of Cancer Research (FOCR));

Event Date: 07/07/2022
Location: Virtual
Subject: Paxlovid Stakeholder Call
FDA Participant/Group: ALEXANDRA SAINT; SHAWN BROOKS; ANDREW LEBOEUF; JOHN FARLEY;
Non FDA Participant/Group: Representatives from various pharmacy organizations and Health and Human Services

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 07/05/2022
Location: Virtual
Subject: FDA's Nutrition Priorities
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Members of Duke University's World Food Policy Center

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 07/07/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: SIOBHAN DELANCEY; JENNIFER ERICKSON; WILLIAM FLYNN; DAVID EDWARDS; CHARLOTTE CONWAY; ANTONIA MONIQUE SENNETT; ANNE NORRIS; JEANETTE MURPHY; TRACEY FORFA;
Non FDA Participant/Group: Members of American Feed Industry Association (AFIA)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top